System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Gianluca Coppola is an expert in Neurology at Sapienza University of Rome (Italy). As of October 2026, ScienceLeadR ranks Gianluca Coppola in the top 1% of experts worldwide for Migraine Disorders, Headache Disorders and Headache. Gianluca Coppola has authored 259 publications, the most recent in 2026, and is an investigator in 9 clinical trials, 2 of them ongoing. SLR score: 907 (community average: 125). How the SLR is computed.

LeadR Profile

Gianluca Coppola Sapienza University of Rome Italy
907 ScienceLeadR Reputation 907

Unlock

Register Login
Network Map

Neurology

Subspecialties: Public Health - Medical Imaging - Genetics

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2007 - 2026
Source: PubMed

Sapienza University of Rome

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 259

Citations

Citations: 7 987 1st author: 61 Last author: 45 Unique author: 4

Main journals

J Headache Pain 59
Cephalalgia 41
Headache 10
Cerebellum 9
Clin Neurophysiol 8

Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Migraine in Older Adults: Age-Related Clinical Features From the Italian RICe Registry.
PMID 42872890 — headache, registries, pain, aging, migraine disorders, aged, diagnosis, therapeutics, nervous system diseases		Eur J Neurol20260
Photophobia in migraine: Electrophysiological analysis of chromatic opponent responses via electroretinogram and visual evoked potential.
PMID 42616083 — headache, evoked potentials, retina, hypersensitivity, migraine disorders, photophobia, retinaldehyde, evoked potentials, visual		Cephalalgia20260
Visual Pathways Involvement in Friedreich's Ataxia Patients Without Macular Impairment.
PMID 42590199 — neural conduction, friedreich ataxia, ataxia, visual pathways, retinaldehyde		J Clin Med20260
CXCL10 knockdown attenuates vestibular migraine in rats by inhibiting PI3K-mediated neuroinflammation and central sensitization.
PMID 42363060 — headache, cytokines, genes, fos, central nervous system sensitization, pain, migraine disorders, vestibular migraine		J Headache Pain20260
SafeTy and effectiveness of Atogepant accoRding to the IHS outcome categories: A multicentric, prospective observational study in real life (the 24-week STAR study).
PMID 42360082 — headache, safety, migraine disorders, therapeutics		Cephalalgia20261

Clinical Studies 9

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1

By phase:

N/A 7
Phase 3 1
Phase 4 1

By status:

Completed 6
Active not recruiting 1
Recruiting 1
Unknown 1

By type:

Interventional 6
Observational 3

By Monocentric/Multicentric:

monocentric 7
multicentric2to4 1
multicentric5to9 0
multicentricup10 1

Main Topics

Ongoing Clinical Trials

2 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Chronology and Sequence of Premonitory Symptoms
NCT07681466 — hypothalamus, migraine disorders, signs and symptoms		N/ARecruiting2026
Italian Real life obServational Study on the effecTiveness sAfety and Tolerability of Atogepant in Migraine Patients
NCT06414044 — headache, safety, pain, migraine disorders, tablets, migraine with aura, headache disorders, prescription drug overuse, migraine without aura, headache disorders, secondary		N/AActive not recruiting2024

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS